nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.114	0.137	CbGbCtD
Minaprine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.107	0.129	CbGbCtD
Minaprine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.107	0.129	CbGbCtD
Minaprine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0969	0.116	CbGbCtD
Minaprine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0969	0.116	CbGbCtD
Minaprine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0836	0.1	CbGbCtD
Minaprine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0812	0.0974	CbGbCtD
Minaprine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0734	0.0881	CbGbCtD
Minaprine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0734	0.0881	CbGbCtD
Minaprine—DRD1—nerve—acquired immunodeficiency syndrome	0.00952	0.0739	CbGeAlD
Minaprine—MAOA—nerve—acquired immunodeficiency syndrome	0.00568	0.0442	CbGeAlD
Minaprine—DRD2—nerve—acquired immunodeficiency syndrome	0.00562	0.0437	CbGeAlD
Minaprine—SLC6A4—blood plasma—acquired immunodeficiency syndrome	0.0053	0.0412	CbGeAlD
Minaprine—MAOA—blood plasma—acquired immunodeficiency syndrome	0.0043	0.0334	CbGeAlD
Minaprine—HTR2A—nerve—acquired immunodeficiency syndrome	0.00371	0.0288	CbGeAlD
Minaprine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.00316	0.0245	CbGeAlD
Minaprine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.0028	0.0218	CbGeAlD
Minaprine—ACHE—spinal cord—acquired immunodeficiency syndrome	0.00277	0.0215	CbGeAlD
Minaprine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00255	0.0198	CbGeAlD
Minaprine—HTR2B—skin of body—acquired immunodeficiency syndrome	0.00252	0.0196	CbGeAlD
Minaprine—MAOA—retina—acquired immunodeficiency syndrome	0.00235	0.0183	CbGeAlD
Minaprine—DRD2—retina—acquired immunodeficiency syndrome	0.00233	0.0181	CbGeAlD
Minaprine—DRD1—nervous system—acquired immunodeficiency syndrome	0.00214	0.0166	CbGeAlD
Minaprine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.00206	0.016	CbGeAlD
Minaprine—SLC6A4—digestive system—acquired immunodeficiency syndrome	0.00204	0.0158	CbGeAlD
Minaprine—HTR2B—digestive system—acquired immunodeficiency syndrome	0.00202	0.0157	CbGeAlD
Minaprine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.00197	0.0153	CbGeAlD
Minaprine—SLC6A4—blood—acquired immunodeficiency syndrome	0.00194	0.0151	CbGeAlD
Minaprine—HTR2B—blood—acquired immunodeficiency syndrome	0.00192	0.0149	CbGeAlD
Minaprine—SLC6A4—spinal cord—acquired immunodeficiency syndrome	0.00187	0.0145	CbGeAlD
Minaprine—ACHE—brain—acquired immunodeficiency syndrome	0.00178	0.0139	CbGeAlD
Minaprine—HTR2B—vagina—acquired immunodeficiency syndrome	0.00178	0.0139	CbGeAlD
Minaprine—ACHE—lymph node—acquired immunodeficiency syndrome	0.00172	0.0134	CbGeAlD
Minaprine—SLC6A4—lung—acquired immunodeficiency syndrome	0.0017	0.0132	CbGeAlD
Minaprine—CHRM1—lung—acquired immunodeficiency syndrome	0.0017	0.0132	CbGeAlD
Minaprine—HTR2B—lung—acquired immunodeficiency syndrome	0.00169	0.0131	CbGeAlD
Minaprine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.00166	0.0129	CbGeAlD
Minaprine—MAOA—digestive system—acquired immunodeficiency syndrome	0.00165	0.0128	CbGeAlD
Minaprine—DRD1—brain—acquired immunodeficiency syndrome	0.00164	0.0127	CbGeAlD
Minaprine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.0016	0.0124	CbGeAlD
Minaprine—SLC6A4—nervous system—acquired immunodeficiency syndrome	0.00158	0.0122	CbGeAlD
Minaprine—MAOA—blood—acquired immunodeficiency syndrome	0.00157	0.0122	CbGeAlD
Minaprine—CHRM1—nervous system—acquired immunodeficiency syndrome	0.00157	0.0122	CbGeAlD
Minaprine—HTR2B—nervous system—acquired immunodeficiency syndrome	0.00156	0.0121	CbGeAlD
Minaprine—HTR2A—retina—acquired immunodeficiency syndrome	0.00154	0.0119	CbGeAlD
Minaprine—SLC6A4—central nervous system—acquired immunodeficiency syndrome	0.00152	0.0118	CbGeAlD
Minaprine—MAOA—spinal cord—acquired immunodeficiency syndrome	0.00152	0.0118	CbGeAlD
Minaprine—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.00151	0.0117	CbGeAlD
Minaprine—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.0015	0.0117	CbGeAlD
Minaprine—MAOA—vagina—acquired immunodeficiency syndrome	0.00146	0.0113	CbGeAlD
Minaprine—MAOA—lung—acquired immunodeficiency syndrome	0.00138	0.0107	CbGeAlD
Minaprine—DRD2—lung—acquired immunodeficiency syndrome	0.00137	0.0106	CbGeAlD
Minaprine—MAOA—nervous system—acquired immunodeficiency syndrome	0.00128	0.00993	CbGeAlD
Minaprine—HTR2C—brain—acquired immunodeficiency syndrome	0.00127	0.00987	CbGeAlD
Minaprine—DRD2—nervous system—acquired immunodeficiency syndrome	0.00126	0.00982	CbGeAlD
Minaprine—MAOA—central nervous system—acquired immunodeficiency syndrome	0.00123	0.00956	CbGeAlD
Minaprine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.00122	0.00946	CbGeAlD
Minaprine—SLC6A4—brain—acquired immunodeficiency syndrome	0.0012	0.00936	CbGeAlD
Minaprine—CHRM1—brain—acquired immunodeficiency syndrome	0.0012	0.00932	CbGeAlD
Minaprine—HTR2B—brain—acquired immunodeficiency syndrome	0.00119	0.00927	CbGeAlD
Minaprine—HTR2B—lymph node—acquired immunodeficiency syndrome	0.00115	0.00896	CbGeAlD
Minaprine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.00108	0.00838	CbGeAlD
Minaprine—HTR2A—blood—acquired immunodeficiency syndrome	0.00103	0.00798	CbGeAlD
Minaprine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.00099	0.00769	CbGeAlD
Minaprine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000982	0.00763	CbGeAlD
Minaprine—MAOA—brain—acquired immunodeficiency syndrome	0.000977	0.00759	CbGeAlD
Minaprine—DRD2—brain—acquired immunodeficiency syndrome	0.000966	0.00751	CbGeAlD
Minaprine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000952	0.0074	CbGeAlD
Minaprine—MAOA—lymph node—acquired immunodeficiency syndrome	0.000944	0.00734	CbGeAlD
Minaprine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000936	0.00727	CbGeAlD
Minaprine—HTR2A—lung—acquired immunodeficiency syndrome	0.000901	0.007	CbGeAlD
Minaprine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000834	0.00648	CbGeAlD
Minaprine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000803	0.00624	CbGeAlD
Minaprine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.00076	0.0059	CbGeAlD
Minaprine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000731	0.00568	CbGeAlD
Minaprine—HTR2A—brain—acquired immunodeficiency syndrome	0.000637	0.00495	CbGeAlD
Minaprine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000581	0.00451	CbGeAlD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000107	0.00285	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000105	0.0028	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000105	0.00279	CbGpPWpGaD
Minaprine—DRD2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000105	0.00278	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000103	0.00275	CbGpPWpGaD
Minaprine—ACHE—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000102	0.00272	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.0001	0.00267	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	9.91e-05	0.00264	CbGpPWpGaD
Minaprine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	9.9e-05	0.00264	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9.78e-05	0.00261	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	9.73e-05	0.00259	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9.62e-05	0.00256	CbGpPWpGaD
Minaprine—MAOA—Metabolism—AGPS—acquired immunodeficiency syndrome	9.62e-05	0.00256	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9.57e-05	0.00255	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	9.42e-05	0.00251	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	9.42e-05	0.00251	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	9.41e-05	0.00251	CbGpPWpGaD
Minaprine—DRD2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	9.41e-05	0.00251	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	9.21e-05	0.00245	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	8.99e-05	0.00239	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.98e-05	0.00239	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	8.89e-05	0.00237	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.85e-05	0.00236	CbGpPWpGaD
Minaprine—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.74e-05	0.00233	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.7e-05	0.00232	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.66e-05	0.00231	CbGpPWpGaD
Minaprine—HTR2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.6e-05	0.00229	CbGpPWpGaD
Minaprine—CHRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.55e-05	0.00228	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	8.48e-05	0.00226	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	8.38e-05	0.00223	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	8.33e-05	0.00222	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.32e-05	0.00222	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.32e-05	0.00222	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.31e-05	0.00221	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.18e-05	0.00218	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.18e-05	0.00218	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.18e-05	0.00218	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.14e-05	0.00217	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.14e-05	0.00217	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.13e-05	0.00217	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	8.13e-05	0.00216	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	8.01e-05	0.00213	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	7.99e-05	0.00213	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	7.95e-05	0.00212	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.92e-05	0.00211	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.8e-05	0.00208	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.75e-05	0.00207	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	7.55e-05	0.00201	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.49e-05	0.00199	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	7.37e-05	0.00196	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.37e-05	0.00196	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.35e-05	0.00196	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.33e-05	0.00195	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	7.25e-05	0.00193	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.23e-05	0.00193	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.19e-05	0.00192	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	7.17e-05	0.00191	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.05e-05	0.00188	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	7.02e-05	0.00187	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.74e-05	0.0018	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.74e-05	0.0018	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	6.65e-05	0.00177	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	6.65e-05	0.00177	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	6.62e-05	0.00176	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	6.6e-05	0.00176	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	6.6e-05	0.00176	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	6.46e-05	0.00172	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.38e-05	0.0017	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.36e-05	0.00169	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.36e-05	0.00169	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.33e-05	0.00169	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.23e-05	0.00166	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	6.23e-05	0.00166	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	6.23e-05	0.00166	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.19e-05	0.00165	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.1e-05	0.00162	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.01e-05	0.0016	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.99e-05	0.0016	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.99e-05	0.0016	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	5.95e-05	0.00158	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	5.92e-05	0.00158	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.75e-05	0.00153	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.7e-05	0.00152	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.69e-05	0.00151	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.66e-05	0.00151	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.65e-05	0.00151	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.65e-05	0.00151	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.61e-05	0.00149	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.58e-05	0.00149	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.44e-05	0.00145	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.44e-05	0.00145	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	5.41e-05	0.00144	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	5.33e-05	0.00142	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	5.33e-05	0.00142	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.14e-05	0.00137	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5.02e-05	0.00134	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.02e-05	0.00134	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5e-05	0.00133	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.95e-05	0.00132	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.94e-05	0.00132	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	4.93e-05	0.00131	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.92e-05	0.00131	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.92e-05	0.00131	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.91e-05	0.00131	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.89e-05	0.0013	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.84e-05	0.00129	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.84e-05	0.00129	CbGpPWpGaD
Minaprine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	4.82e-05	0.00128	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.8e-05	0.00128	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.8e-05	0.00128	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	4.8e-05	0.00128	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.74e-05	0.00126	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.72e-05	0.00126	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.72e-05	0.00126	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	4.7e-05	0.00125	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.7e-05	0.00125	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.7e-05	0.00125	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.7e-05	0.00125	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.7e-05	0.00125	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.67e-05	0.00124	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.62e-05	0.00123	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.62e-05	0.00123	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.6e-05	0.00123	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.6e-05	0.00123	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.56e-05	0.00121	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.54e-05	0.00121	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.52e-05	0.00121	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.49e-05	0.0012	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.47e-05	0.00119	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.44e-05	0.00118	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	4.37e-05	0.00116	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.34e-05	0.00116	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.3e-05	0.00115	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.27e-05	0.00114	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.27e-05	0.00114	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.27e-05	0.00114	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.27e-05	0.00114	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.25e-05	0.00113	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.24e-05	0.00113	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.2e-05	0.00112	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.2e-05	0.00112	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	4.19e-05	0.00112	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.18e-05	0.00111	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.18e-05	0.00111	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.16e-05	0.00111	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.11e-05	0.00109	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.05e-05	0.00108	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.99e-05	0.00106	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.93e-05	0.00105	CbGpPWpGaD
Minaprine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.89e-05	0.00104	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.87e-05	0.00103	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.77e-05	0.001	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.68e-05	0.00098	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.65e-05	0.000972	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.62e-05	0.000965	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.62e-05	0.000965	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.58e-05	0.000952	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.55e-05	0.000946	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.55e-05	0.000944	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.54e-05	0.000943	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.54e-05	0.000943	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.52e-05	0.000938	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.52e-05	0.000937	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.5e-05	0.000932	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.47e-05	0.000923	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.45e-05	0.000918	CbGpPWpGaD
Minaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.38e-05	0.0009	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.36e-05	0.000895	CbGpPWpGaD
Minaprine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.36e-05	0.000895	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.34e-05	0.000889	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.34e-05	0.000889	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.31e-05	0.000883	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.25e-05	0.000865	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.22e-05	0.000858	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.2e-05	0.000852	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.19e-05	0.000851	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.18e-05	0.000846	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.17e-05	0.000844	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.15e-05	0.00084	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.15e-05	0.000838	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.13e-05	0.000834	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.04e-05	0.000809	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.97e-05	0.00079	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.93e-05	0.000779	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.92e-05	0.000777	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.9e-05	0.000773	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.88e-05	0.000767	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.86e-05	0.000763	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.86e-05	0.000761	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.86e-05	0.000761	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.69e-05	0.000718	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.68e-05	0.000714	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.65e-05	0.000707	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.64e-05	0.000703	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.62e-05	0.000699	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.61e-05	0.000696	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.54e-05	0.000677	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.52e-05	0.000672	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.52e-05	0.000672	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.5e-05	0.000667	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.48e-05	0.000661	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.48e-05	0.000661	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.47e-05	0.000657	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.47e-05	0.000657	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.47e-05	0.000657	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.43e-05	0.000646	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.37e-05	0.000632	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.29e-05	0.00061	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.24e-05	0.000596	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.17e-05	0.000579	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.14e-05	0.00057	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.11e-05	0.000562	CbGpPWpGaD
Minaprine—ACHE—Metabolism—ALB—acquired immunodeficiency syndrome	2.09e-05	0.000558	CbGpPWpGaD
Minaprine—MAOA—Metabolism—ALB—acquired immunodeficiency syndrome	1.97e-05	0.000525	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.96e-05	0.000522	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.92e-05	0.000511	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.92e-05	0.00051	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.89e-05	0.000503	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.89e-05	0.000503	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.88e-05	0.0005	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.86e-05	0.000496	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.86e-05	0.000495	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.85e-05	0.000493	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.83e-05	0.000488	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.82e-05	0.000485	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.73e-05	0.00046	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.7e-05	0.000453	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.69e-05	0.00045	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.69e-05	0.00045	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.66e-05	0.000443	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.65e-05	0.000441	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.4e-05	0.000373	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.4e-05	0.000372	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000352	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.32e-05	0.00035	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.13e-05	0.000301	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.13e-05	0.0003	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.98e-06	0.000266	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.93e-06	0.000265	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.82e-06	0.000262	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.78e-06	0.00026	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.77e-06	0.00026	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.72e-06	0.000259	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	8.59e-06	0.000229	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.24e-06	0.00022	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.77e-06	0.000207	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.65e-06	0.000177	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.87e-06	0.000156	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.77e-06	0.000154	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.74e-06	0.000153	CbGpPWpGaD
